Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • ENT
    • New method improves...

    New method improves aphasia treatment after stroke

    Written by Anjali Nimesh Nimesh Published On 2018-07-04T19:25:43+05:30  |  Updated On 4 July 2018 7:25 PM IST
    New method improves aphasia treatment after stroke

    A new treatment has been shown to significantly improve the speech and word production, Aphasia of stroke patients.


    The treatment- developed by a speech therapist and cognitive neuroscientists at The University of Manchester- uses special software which gradually makes patients produce words increasingly quickly.


    The researchers have published their findings in the journal Brain and they hope that the treatment will eventually improve the ability of stroke patients with aphasia across the NHS to access intensive treatment, and improve their symptoms and speech recovery after stroke.


    The new treatment- tested on 20 stroke patients – was shown by the researchers to be around twice as effective in terms of words deployed by the patients in their speech.


    The treatment, which is administered over several training sessions, uses photos shown on a laptop, initially giving patients 3 seconds to react. Gradually, the time is reduced, aiming to achieve a response of 1 second – which is normal for people over 65.


    The research was funded by the Medical Research Council, the Rosetrees Trust and the European Research Council.


    The researchers are based at the University of Manchester’s Neuroscience and Aphasia Research Unit.


    Dr Paul Conroy, Clinical Lecturer in Speech and Language Therapy, said “We know from Stroke Association data that there are more than 100,000 strokes in the UK each year, that is around one stroke every five minutes.


    “So there are over 1.2 million stroke survivors in the UK and about one third of stroke survivors will have aphasia as a long term disability.”


    Dr Conroy explained: “And though symptoms can vary, the consequences of aphasia at its worst can be devastating; not being able to use words, understand, read or write words can be very tough even at the less affected end of the spectrum.


    “So we’re excited this new approach seems to yield significant benefits.”


    The researchers tested three measures, each compared to standard speech therapy treatment – and then retested the patients after a month.


    The accuracy of the patients’ word retrieval was 25% better with the treatment and 10% better with the standard treatment.


    Deployment - the use of words appropriately in speech – rose from 17% to 59% after treatment, compared to 14% to 33% with standard treatment. Patients with no treatment at all improved from 15% to 24% - so the impact of standard treatment was limited.


    And in terms of speed of response, patients improved from 3 seconds to 1.6 seconds with the new treatment and 3 seconds to 2 seconds with standard treatment. However, the effect of the standard treatment was lost after a month whereas the effect of the new treatment remained.


    Professor Matthew Lambon Ralph who is a cognitive neuroscientist said: “This is a novel approach: we had not really considered before that speed of naming seems to play an important part in speech therapy.”


    “It’s cheap, quick to administer and more effective than current treatments.


    “However, now that we have proof of principle, we hope to move on to a larger scale multi-centre trial.


    “But our ultimate aim is for this treatment to be available for the NHS within 5 years.”


    The paper ‘Time for a quick word? The striking benefits of training speed and accuracy of word retrieval in post-stroke aphasia’ is published in Brain.

    journal BrainsoftwarespeechstrokeThe University of Manchestertherapisttherapy
    Source : With inputs from Brain

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Anjali Nimesh Nimesh
    Anjali Nimesh Nimesh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok